View Older Stories View More Recent Stories
-
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at 34th Annual Roth Conference
-
Wrap Technologies to Present at the 34th Annual Roth Conference on March 13-15, 2022
-
Marchex to Present at the 2022 Roth Capital Partners Conference
-
Creative Medical Technology to Participate in the 34th Annual Roth Conference
-
ME2C® Environmental to Present at the 34th Annual ROTH Conference
-
ME2C® Environmental to Present at the 34th Annual ROTH Conference
-
AcuityAds to Participate in the 34th Annual Roth Conference
-
InMed to Present at the 34th Annual Roth Conference
-
InMed to Present at the 34th Annual Roth Conference
-
First Wave BioPharma to Participate in ”Fireside Chat” at the 34th Annual Roth Conference
-
Aytu BioPharma Announces Closing of $7.6 Million Registered Offering
-
Khiron Life Sciences to Present at Upcoming March Investor Conferences
-
InvestorNewsBreaks – Roth Capital Partners LLC to Host 34th Annual Conference as In-Person Event
-
B2i Digital Showcases Participating Companies at 34th Annual Roth Conference as Part of Marketing Sponsorship
-
Aviat Networks to Participate at the 34th Annual Roth Conference
-
Roth Capital Partners to Host 34th Annual Conference as In-Person Event March 13-15, 2022
-
Roth Capital Partners to Host 34th Annual Conference as In-Person Event March 13-15, 2022
-
GBS Inc. to Participate in the Upcoming March Investor Conferences
-
Winc to Participate in the 34th Annual Roth Conference
-
Manitex International to Participate in Roth Capital Conference
-
Agrify to Participate in the 34th Annual Roth Conference
-
Proactive news headlines including Tamboran Resources, Imugene Ltd, Emperor Energy and Pantoro Ltd
-
Proactive news headlines including Tamboran Resources, Imugene Ltd, Emperor Energy and Pantoro Ltd
-
Limbach Holdings to Attend the 34th Annual ROTH Conference on March 14 and 15, 2022
-
Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th
-
Burcon to Participate in Upcoming Investor Conferences
-
Mydecine To Attend March Investor Conferences
-
Mydecine To Attend March Investor Conferences
-
Perion Network to Participate at the 34th Roth Capital Conference, in California, on Monday, March 14
-
Aytu BioScience (AYTU) Prices 3.03M Share and Warrant Offering at $1.25/sh
-
Aytu BioPharma Announces Pricing of $7.6 Million Registered Offering
-
Dynatronics Corporation Announces Participation in Upcoming Investor Conferences
-
CleanTech Acquisition Corp. and Nauticus Robotics to Present at the 34th Annual ROTH Conference
-
SAFE-T GROUP TO PARTICIPATE AT THE 34th ANNUAL ROTH CONFERENCE
-
CleanTech Acquisition Corp. and Nauticus Robotics to Present at the 34th Annual ROTH Conference
-
SAFE-T GROUP TO PARTICIPATE AT THE 34th ANNUAL ROTH CONFERENCE
-
LSI Industries to Attend the 34th Annual Roth Conference
-
Vivos Therapeutics to Participate in Upcoming Investor Conferences
-
Better Choice Company to Participate in Upcoming Investor Conferences in March 2022
-
InvestorNewsBreaks – Roth Capital Partners LLC’s Suji Desilva Discusses Identifying Tech Trends, Profitable Business Models in NetworkNewsAudio Interview
-
IBN (InvestorBrandNetwork) Announces NetworkNewsAudio Interview featuring Suji Desilva, Senior Research Analyst at Roth Capital Partners
-
IDEAYA Biosciences to Participate in Investor Conferences in March 2022
-
EdgarAgents To Co-Sponsor The 34th Annual Roth Conference
-
EdgarAgents To Co-Sponsor The 34th Annual Roth Conference
-
Flora Growth Completes Acquisition of Category Leading Wellness Brand JustCBD; Enhances U.S. Infrastructure and CPG Portfolio
-
OSS to Present at the 34th Annual ROTH Conference, March 13-15, 2022
-
Global Self Storage to Present at the 34th Annual ROTH Conference, March 13-15, 2022
-
OSS to Present at the 34th Annual ROTH Conference, March 13-15, 2022
-
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
-
Energous Corporation Reports 2021 Fourth-Quarter and Full-Year Financial Results
